Thermo Fisher Scientific (TMO) Total Non-Current Liabilities (2009 - 2026)

Thermo Fisher Scientific has reported Total Non-Current Liabilities for 18 years, with the latest figure at $108.6 billion in Q2 2026.

• Total Non-Current Liabilities for Q2 2026 came in at $108.6 billion, up 12.04% year-over-year; the trailing twelve-month figure through Jun 2026 was $108.6 billion (up 12.04% YoY), and the FY2025 annual result was $106.1 billion, up 13.65% from the prior year.
• Total Non-Current Liabilities held at $108.6 billion in Q2 2026, from $108.9 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $108.9 billion in Q1 2026 and troughed at $86.0 billion in Q3 2022.
• A 5-year average of $95.0 billion and a median of $93.7 billion in 2023 frame the typical range for Total Non-Current Liabilities.
• The widest annual swing landed in 2022, when Total Non-Current Liabilities jumped 40.75%; it then slipped 0.8% in 2024.
• A 5-year view of Total Non-Current Liabilities shows it stood at $92.9 billion in 2022, then increased by 1.26% to $94.1 billion in 2023, then retreated by 0.8% to $93.3 billion in 2024, then climbed by 13.65% to $106.1 billion in 2025, then grew by 2.42% to $108.6 billion in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $108.6 billion in Q2 2026, $108.9 billion in Q1 2026, and $106.1 billion in Q4 2025.